Is the Clinical Research Enterprise in Decline?

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. It looks like the ‘new normal’ is not just for biotechnology startups and SME pharma companies  – the CROs (and other vendors) who previously benefited from better R&D funding streams also […]


Get email updates

Get new actionable insights and updates from BiotechBlog

Do NOT follow this link or you will be banned from the site!